Shareholders in Charles River Laboratories International (NYSE:CRL) Are in the Red If They Invested Three Years Ago
CRL Stock May Benefit From New Neuroscience Research Collaboration
Intel, Moderna And Dollar General Were Among Top 10 Large Cap Losers In August: Are The Others In Your Portfolio?
Why Is Charles River (CRL) Down 5.3% Since Last Earnings Report?
Higher Interest Environment Negatively Impacted Charles River Laboratories (CRL)
Zacks.com Featured Highlights Include Vertiv, Charles River Associates, Cabot, Leidos and HCA Healthcare
Charles River and Insightec Announce Strategic Collaboration to Advance Therapeutic Development Utilizing Focused Ultrasound in Neuroscience
Neptune Flood Reaches Milestone of 200,000 Policies and $250 Million of Premium in Force
Charles River Laboratories to Present at Baird and Morgan Stanley Conferences
Magnificent 7 Miss Out, 2 Cybersecurity Stocks Stand Firm, Retailers Lag In Volatile August: Here Are The Top S&P 500 Gainers And Losers
Super Micro's Precipitous August Stock Selloff Can Be Summed up by These Stats
Charles River Laboratories International (CRL) Fell Due to a More Cautious Funding Environment
Is Wall Street Bullish or Bearish on Charles River Laboratories Stock?
Should You Investigate Charles River Laboratories International, Inc. (NYSE:CRL) At US$205?
Reasons Why You Should Bet on Charles River (CRAI) Stock Now
Zacks.com Featured Highlights Leidos, Trane, Cabot, Vertiv and Charles River
Charles River Associates (CRA) Strengthens Its Energy Practice
S&P 500 Futures Steady In Premarket Trading; United Therapeutics, Tempus AI Lead
Terumo and Charles River Demonstrate Effectiveness of CGT Manufacturing Device
Medicare's Negotiated Drug Prices Will Save Taxpayers $6 Billion in First Year, White House Says